Beta1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer. (Q54711475)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Beta1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer. |
scientific article |
Statements
Beta1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer. (English)
1 reference
David Lesniak
1 reference
Yaoxian Xu
1 reference
Jean Deschenes
1 reference
Raymond Lai
1 reference
John Thoms
1 reference
David Murray
1 reference
Sunita Gosh
1 reference
John R Mackey
1 reference
Siham Sabri
1 reference
Bassam Abdulkarim
1 reference
3 November 2009
1 reference
69
1 reference
22
1 reference
8620-8628
1 reference
Identifiers
1 reference